The immunopathogenic and immunomodulatory effects of interleukin‐12 in periodontal disease

Abstract

Interleukin 12 (IL-12) is an inflammatory cytokine that promotes the response of the immune system. This cytokine has been implicated as a potent stimulator of several diseases characterized by inflammatory-induced bone destruction, such as rheumatoid arthritis and periodontitis. Yet, the exact role of IL-12 in the development and progress of periodontitis has not been clarified. Several studies have demonstrated a positive correlation between the level of IL-12 and the severity of periodontal destruction. Deletion of IL-12 in mice with periodontitis significantly suppressed the level of bone destruction. Interestingly, next to a role in modulating the pathogenesis, IL-12 also has immunological-regulatory properties. This cytokine induces expression of immunosuppressive molecules, such as indoleamine-pyrrole 2,3-dioxygenase (IDO). Thus, these findings suggest both negative and positive influences of IL-12 in periodontal disease. It is currently proposed that the diversity of action of cytokines is a molecular key which regulates biological development and homeostasis. Accordingly, the actions of IL-12 might be one of the mechanisms that regulate homeostasis of periodontal tissue during and following inflammation. Therefore, this article aims to review both destructive and protective functionalities of IL-12 with an emphasis on periodontal disease.

Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population

“…Inflammation and immune response play key role in periodontal diseases such as gingivitis and periodontitis, which are considered to be the most common complications of diabetes (Karjalainen and Knuuttila, 1996 ). Additionally, the osteolytic role of the proinflammatory cytokine interleukin IL-12 was recently found to be involved in the pathogenesis of periodontal diseases (Issaranggun Na Ayuthaya et al, 2018 ). Differentially expressed proteins in these pathways, that could contribute to periodontal disease, are presented in Table 2 .…”

Deciphering desirable immune responses from disease models with resistant and susceptible chickens

“…Garrido et al, (2018) reported that IFN-α induced the expression of ISG (at 6h post stimulation) by chicken macrophages to a greater extent than IFN-β (while IFN-β was a stronger inducer of pro-inflammatory cytokine gene expression (IL-1β, IL-6, and IL-8)). IL-12, produced by various immune cells (e.g., dendritic cells, macrophages, neutrophils), drives inflammatory Th1 responses, production of IFN-γ, and the cytotoxic activity of NK and CD8+ T cells (Issaranggun Na Ayuthaya et al, 2018). IL-17D is a member of the IL-17 family of cytokines produced by Th17 cells, is expressed in a wide range of tissues and organs, and stimulates the expression of IL-6 and IL-8 by various cells (Min et al, 2013).…”

Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice

“…Both IL-12 and IL-35 share the same subunit, the IL-12p35 subunit, and belong to the IL-12 family. Recent studies have also reported that IL-12 could play both anti-inflammatory and proinflammatory roles depending on the different inflammatory microenvironment [ [11] , [12] , [13] ]. In the cardiovascular system, IL-22 could aggravate atherosclerosis via amplifying inflammation [ 14 ].…”